The morning briefing opens with a sobering note on inflation, a subject that has dominated markets and policy circles alike. The U.S. Consumer Price Index (CPI) for July, released today, showed a modest 0.2% increase over the prior month, a figure that, while slightly above expectations, underscores the persistent challenge of moderating inflation without triggering economic disruption. Core CPI, which excludes volatile food and energy prices, also held steady at 0.2%, suggesting that underlying inflationary pressures remain contained. However, the broader economic context is anything but simple. The July jobs report, which fell short of forecasts, and the ongoing geopolitical tensions surrounding the Strait of Hormuz, where Iran’s stance continues to complicate energy market stability, have amplified uncertainty. Meanwhile, the Federal Reserve’s next policy decision—whether to hike rates or hold steady—remains a focal point, with markets weighing the risk of a hawkish stance against the potential for economic slowdown. The interplay between inflation data, energy prices, and global supply chains has created a volatile backdrop, forcing investors to recalibrate their expectations for the remainder of the year.
The AI sector, however, has emerged as a critical counterbalance to these macroeconomic headwinds. CoreWeave and Supermicro Computer, two firms at the heart of the AI infrastructure boom, delivered earnings that exceeded forecasts, reinforcing the sector’s resilience. CoreWeave’s Q2 results, driven by sustained demand for AI chips and cloud computing, saw its stock surge over 15% in premarket trading, while Supermicro’s 7% jump reflected similar optimism. These gains were not isolated; they were amplified by broader market sentiment favoring AI-related assets, which have become a cornerstone of long-term growth strategies. The earnings reports also highlighted the sector’s ability to navigate inflationary pressures, as companies leveraged scale and efficiency to offset rising costs. Yet, the AI narrative is not without its complexities. The rapid expansion of data centers, which underpin this technological revolution, has sparked debates over their environmental impact and regulatory scrutiny, as seen in the growing opposition from local communities and policymakers.
Beyond the tech sector, the political landscape continues to shape market dynamics. The Wisconsin primary, where David Crowley narrowly defeated Francesca Hong, has sent shockwaves through the Democratic Party, exposing deep ideological fissures. This outcome may force the party to confront its messaging and priorities ahead of the midterms, with implications for policy agendas and regulatory environments. Simultaneously, the Trump administration’s approach to foreign policy—particularly its stance on the Strait of Hormuz—has introduced new variables into the geopolitical equation. The president’s claims of “total control” over the waterway, coupled with ongoing tensions with Iran, have heightened concerns about energy security and global trade disruptions. These factors, combined with the Federal Reserve’s potential policy shifts, create a multifaceted risk profile for investors. As markets grapple with these interwoven challenges, the ability to discern signal from noise will be paramount, requiring a nuanced understanding of both macroeconomic trends and micro-level developments.
The day’s outlook is further complicated by the interplay of global energy markets and inflationary forces. Brent crude prices, nearing $90 per barrel, and West Texas Intermediate futures, up over 25% since the Iran conflict began, signal a potential resurgence of inflationary pressures. Analysts warn that a prolonged disruption in the Strait of Hormuz could exacerbate these trends, driving up energy costs and straining consumer budgets. This scenario would not only test the resilience of global supply chains but also amplify the Federal Reserve’s dilemma: balancing inflation control with economic growth. The Bank of Japan’s potential rate hikes, in response to domestic inflation, could further complicate this dynamic, as the carry trade—a key driver of capital flows—faces existential threats. For investors, these developments underscore the importance of monitoring both direct and indirect impacts of geopolitical events on financial markets.
In parallel, the real estate sector has become an unexpected focal point, with data showing that over 1.5% of U.S. home sales now occur within 5 miles of data centers. While this figure remains modest, it reflects a growing recognition of the infrastructure’s economic footprint. However, the rapid expansion of these facilities has also sparked regulatory pushback, as seen in states like New York and Texas, where local governments have imposed moratoriums on new projects. This tension between technological progress and community concerns highlights the broader challenge of aligning innovation with societal needs. For investors, the implications are twofold: the potential for long-term value creation in data center real estate, and the risk of regulatory headwinds that could stifle growth. As the market navigates these competing forces, the ability to anticipate and adapt to shifting dynamics will define the success of portfolios in the coming months.
The convergence of these factors—inflationary pressures, geopolitical risks, AI-driven growth, and regulatory scrutiny—creates a landscape of both opportunity and uncertainty. Markets are increasingly attuned to the nuances of these interdependencies, with investors weighing the potential for AI to offset inflationary trends against the risks of overreliance on speculative tech bets. At the same time, the political and energy-related variables introduce layers of complexity that demand vigilance. For those who can synthesize these elements into a coherent framework, the path forward may offer avenues for growth, but for the unprepared, the stakes are high. The morning’s briefing serves as a reminder that in an era of rapid change, the most effective strategies will be those that balance foresight with flexibility, anchored in a deep understanding of the forces shaping the global economy.
IAN Financial Vision is an AI-native financial research platform combining proprietary knowledge graphs, quantitative valuation models, and large language models to generate point-in-time investment research. All reports are produced using a structured research workflow with human review prior to publication..
Watch List
EIC
Eagle Point Income Company Inc. announced its planned conversion from a Delaware corporation to a Delaware Statutory Trust, set to take effect on August 24, 2026. This conversion, approved by shareholders and the Board of Directors, will result in the company’s name changing to Eagle Point Income Company. As part of the restructuring, each outstanding share of common and preferred stock will convert into an equivalent share of beneficial interest, maintaining the same designations and terms. Stockholders do not need to take any action to facilitate this change. The company provided an estimated net asset value per share of common stock as of July 31, 2026, ranging from $12.30 to $12.40. However, the company cautioned that forward-looking statements contained within the filing are not guarantees and are subject to various risks and uncertainties, as detailed in its prospectus and other SEC filings. The company has indicated it does not intend to update these forward-looking statements.
ALT
Altimmune, Inc. recently announced its second-quarter financial results for the period ending June 30, 2026, as detailed in a press release furnished as Exhibit 99.1 to this Form 8-K filing. While specific financial figures were not included in this report, the announcement signals a key update for investors regarding the company’s performance. This filing serves as a notification to the public regarding the release of these results, providing transparency into Altimmune’s financial standing at the close of the second quarter. The document itself, a Form 8-K, focuses on disseminating the press release rather than containing the detailed financial statements and exhibits typically associated with this type of reporting. Investors seeking a comprehensive overview of Altimmune’s financial health should consult the accompanying press release.
XLO
Xilio Therapeutics, Inc. recently announced its financial results for the quarter ended June 30, 2026, alongside key business updates. The company’s performance for the period was detailed in a press release, which is attached as Exhibit 99.1 to this Form 8-K and incorporated into the filing for informational purposes. While a formal financial statement isn’t being filed as part of this report, the announcement provides stakeholders with a snapshot of the company’s current standing and recent developments. This filing serves as a notification of the results and highlights key business activities undertaken by Xilio Therapeutics, Inc. during the specified reporting period.
BWAY
BrainsWay Ltd. (BWAY) reported a strong second quarter of 2026, demonstrating significant growth and operational improvements. Revenue increased by 35% to $17.1 million, driven by a record 125 shipments of Deep TMS™ systems, a 42% year-over-year increase, bringing the total installed base to approximately 1,949. Adjusted EBITDA more than doubled to $3.5 million with a healthy 20% margin, up from 11% the prior year. Remaining performance obligations (RPOs) rose to $80.4 million, reflecting continued demand for the company’s technology. The company’s focus on expanding insurer coverage for its SWIFT™ protocol and presenting real-world data on PTSD and MDD treatment further bolstered its position. BrainsWay also continued to strategically invest in its minority portfolio companies, Hopemark Health and Radial Health. Looking ahead, the company raised its full-year 2026 revenue guidance to $68 million to $70 million, representing approximately 30% to 34% growth compared to 2025. With a strong operational foundation and expanding market acceptance, BrainsWay’s CEO, Hadar Levy, highlighted the company’s momentum and reaffirmed its commitment to advancing neuroscience and transforming mental health treatment. The company will host a conference call and webinar to discuss these results in detail.
ABUS
Arbutus Biopharma Corporation reported a mixed second quarter of 2026, marked by key developments in its imdusiran program and a significant milestone in its Moderna settlement. The company received the first payment of approximately $178 million from the Moderna settlement, with expectations to return up to $230 million to shareholders through potential repurchases. Simultaneously, Arbutus filed three international patent lawsuits against Pfizer and BioNTech regarding LNP technology. Notably, the company achieved alignment with the FDA on a Phase 2b clinical trial design for imdusiran, a novel RNAi therapeutic targeting chronic hepatitis B (cHBV), following Fast Track designation for the drug, which has demonstrated functional cures in early trials. Despite revenue declining to $1 million due to the recognition of deferred revenue, Arbutus is focused on returning capital to shareholders and continuing the development of imdusiran, which aims to address a significant unmet medical need affecting over 250 million people worldwide. The company’s ongoing clinical trials have shown promising results, with eight patients achieving functional cure in Phase 2a trials and further demonstrating the drug’s potential to reduce HBsAg and HBV DNA.
LOCL
Local Bounti Corporation, a U.S. indoor agriculture company servicing approximately 13,000 retail doors, announced a strong second quarter of 2026, reporting 14% revenue growth to $13.9 million, alongside a narrowed net loss of $19.8 million and a 17% reduction in adjusted EBITDA loss to $5.8 million. This positive performance was driven by increased production, bolstered by approximately 10% yield improvements at its state-of-the-art facilities, and expanded retail partnerships, including securing agreements with five new retailers and extending supply arrangements with national accounts through early 2027. The company also secured an additional $12.5 million investment from an existing strategic investor, signaling continued confidence in its platform. Gross profit increased to $1.0 million, although the adjusted gross margin percentage decreased slightly due to temporary packing inefficiencies resolved at its Georgia facility. General and administrative expenses were reduced by $0.5 million through cost savings measures, contributing to a 17% decrease in adjusted general and administrative expense. Looking ahead, Local Bounti anticipates continued sequential improvements in revenue and adjusted EBITDA, fueled by ongoing sales growth and cost reduction initiatives, with a key focus on achieving positive adjusted EBITDA. The company is also investing in its California facilities to further enhance yields and operational efficiency, aiming for a 20% improvement. With approximately 23.2 million shares outstanding and a strong base of blue-chip retail relationships, Local Bounti is focused on its mission to revolutionize agriculture and deliver fresh, sustainable produce, leveraging its patented Stack & Flow Technology to meet growing consumer demand for traceable and locally-grown food.
STRO
Sutro Biopharma, Inc. recently announced its financial results for the quarter ended June 30, 2026, issuing a press release that has been attached as Exhibit 99.1 to this SEC filing. While specific details regarding the company’s performance during the period were not included in this filing, the announcement signals a key update for investors and stakeholders. This report serves as a notification of the release, providing a formal record of the company’s communication regarding its financial standing and operational results. The filing highlights Sutro Biopharma’s commitment to transparency and timely reporting, allowing the market to receive crucial information directly from the source. Further details regarding the financial performance can be found within the attached press release.
NVA
Nova Minerals Corp. recently issued a press release, attached as Exhibit 99.1, detailing an update on its planned activities for the 2026 field season. This announcement, titled “Nova Minerals Provides an Update on Its 2026 Field Season Activities,” provides investors with insights into the company’s operational strategy and upcoming initiatives. The filing, submitted as an Item 7.01 under Regulation FD, serves as a notification of this press release and does not constitute filed financial information. Importantly, the information contained within this release is not intended to be incorporated into any future filings or documents, such as registration statements, and should be viewed as an initial update regarding Nova Minerals’ 2026 field season plans.
LXEO
Lexeo Therapeutics, Inc. recently released a press statement and updated corporate presentation to highlight key business developments and financial performance for the periods ending June 30, 2026. The company’s August 12th announcement, furnished as Exhibit 99.1, detailed these results and provided an overview for investors and analysts. Furthermore, Lexeo updated its corporate presentation, now available as Exhibit 99.2, which will be utilized in ongoing communications with stakeholders. These disclosures represent a timely update on the company’s current standing and strategic direction, offering investors a comprehensive view of Lexeo Therapeutics’ performance and plans.
CDLR
Cadeler has entered into a strategic transaction to acquire Menck, a specialist technology provider focused on hydraulic hammers and related services for offshore wind foundation installation. This move significantly strengthens Cadeler’s capabilities across the entire foundation value chain, aiming to improve execution certainty and differentiate the company as a trusted, end-to-end partner in complex offshore wind projects. Menck’s expertise, including decades of experience, a global fleet, and a robust track record utilizing data from 50 million pile driving operations, will be integrated with Cadeler’s industry-leading fleet and relationships. The acquisition focuses on providing mission-critical equipment, encompassing hydraulic hammers capable of delivering up to 4,400 kJ of energy, alongside services like grouting, drilling, and lifting. Menck’s technology, including noise mitigation solutions and digital monitoring, is designed to address the increasing demands of larger turbines and monopiles, while also supporting compliance with evolving environmental regulations. The transaction is projected to contribute approximately 8% to Cadeler’s 2029 revenue, capitalizing on the growing market for larger, more complex offshore wind projects and offering Cadeler enhanced flexibility and risk mitigation capabilities through its expanded equipment portfolio and operational agility.
Economic Calendar
IAN Financial Vision is an AI-native financial research platform combining proprietary knowledge graphs, quantitative valuation models, and large language models to generate point-in-time investment research. All reports are produced using a structured research workflow with human review prior to publication..
| Date | Event | Previous | Impact |
|---|---|---|---|
| 2026-08-12 06:00:00 | OPEC Monthly Report | NaN | ⭐️⭐️ |
| 2026-08-12 07:00:00 | MBA Mortgage Market Index (Aug/07) | 240.000 | ⭐️ |
| 2026-08-12 07:00:00 | MBA 30-Year Mortgage Rate (Aug/07) | 6.810 | ⭐️⭐️ |
| 2026-08-12 07:00:00 | MBA Mortgage Applications (Aug/07) | -2.900 | ⭐️ |
| 2026-08-12 07:00:00 | MBA Mortgage Refinance Index (Aug/07) | 709.100 | ⭐️ |
| 2026-08-12 07:00:00 | MBA Purchase Index (Aug/07) | 154.000 | ⭐️ |
| 2026-08-12 08:30:00 | Core CPI MoM (Jul) | 0.000 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | CPI s.a (Jul) | 332.568 | ⭐️⭐️ |
| 2026-08-12 08:30:00 | Core Inflation Rate YoY (Jul) | 2.600 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | CPI (Jul) | 333.950 | ⭐️⭐️ |
| 2026-08-12 08:30:00 | CPI MoM (Jul) | -0.400 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | Real Earnings MoM (Jul) | 0.800 | ⭐️ |
| 2026-08-12 08:30:00 | Inflation Rate YoY (Jul) | 3.500 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | CPI YoY (Jul) | 3.500 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | Core CPI YoY (Jul) | 2.600 | ⭐️⭐️ |
| 2026-08-12 08:30:00 | Inflation Rate MoM (Jul) | -0.400 | ⭐️⭐️⭐️ |
| 2026-08-12 08:30:00 | Core CPI (Jul) | 336.070 | ⭐️ |
| 2026-08-12 08:30:00 | Core Inflation Rate MoM (Jul) | 0.000 | ⭐️⭐️⭐️ |
| 2026-08-12 10:30:00 | EIA Crude Oil Imports Change (Aug/07) | 0.297 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Weekly Refinery Utilization Rates WoW | -0.700 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Crude Oil Stocks Change (Aug/07) | 2.479 | ⭐️⭐️ |
| 2026-08-12 10:30:00 | EIA Gasoline Production Change (Aug/07) | -0.309 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Refinery Crude Runs Change (Aug/07) | -0.183 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Distillate Stocks Change (Aug/07) | -3.473 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Cushing Crude Oil Stocks Change (Aug/07) | 2.356 | ⭐️ |
| 2026-08-12 10:30:00 | Crude Oil Imports | 0.297 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Heating Oil Stocks Change (Aug/07) | -0.144 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Distillate Fuel Production Change (Aug/07) | -0.134 | ⭐️ |
| 2026-08-12 10:30:00 | EIA Gasoline Stocks Change (Aug/07) | -1.643 | ⭐️⭐️ |
| 2026-08-12 11:00:00 | Thomson Reuters IPSOS PCSI (Aug) | 50.990 | ⭐️ |
| 2026-08-12 11:30:00 | 17-Week Bill Auction | 3.785 | ⭐️ |
| 2026-08-12 12:00:00 | WASDE Report | NaN | ⭐️⭐️ |
| 2026-08-12 13:00:00 | 10-Year Note Auction | 4.580 | ⭐️ |
| 2026-08-12 14:00:00 | Budget Balance (Jul) | -120.000 | ⭐️⭐️ |
| 2026-08-12 14:00:00 | Monthly Budget Statement (Jul) | -120.000 | ⭐️⭐️ |